Provider Perspectives on the Acceptability, Appropriateness, and Feasibility of Teleneonatology.
Jennifer L Fang, Rachel Umoren, Hilary Whyte...
https://pubmed.ncbi.nlm.nih.gov/34583392/Actively Recruiting
Led by Mayo Clinic · Updated on 2025-11-21
947
Participants Needed
36
Research Sites
11 weeks
Total Duration
Researchers are evaluating the impact of real-time audio-video telemedicine consultations with a neonatologist, called teleneonatology, on early health outcomes of at-risk newborns delivered in community hospitals. This study uses a stepped wedge cluster randomized design to compare early mortality, morbidity, and delivery room care between neonates receiving teleneonatology support and those receiving usual care. The trial is led by Mayo Clinic and focuses on newborns facing significant resuscitation needs shortly after birth. The study involves two groups one where at-risk neonates receive care from the community hospital team with telemedicine support from a neonatologist located at a regional neonatal intensive care unit, and a control group where neonates receive the hospitals usual care without telemedicine consultation. The telemedicine connection allows real-time, two-way audio and video communication during advanced neonatal resuscitations. The study includes neonates born preterm under 32 weeks or requiring advanced resuscitation interventions such as prolonged positive pressure ventilation, alternative airway placement, or chest compressions. Participants include clinicians attending newborn resuscitations and eligible neonates born at participating community hospitals. Researchers will monitor outcomes including mortality within 7 days, early neonatal morbidity, combined mortality and morbidity, and the highest level of resuscitation given in the delivery room within the first hour. The study tracks these outcomes to assess the effect of teleneonatology on newborn health during this critical early period. The total study duration extends through May 2029.
CONDITIONS
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
J
Jennifer Fang, MD, MS
B
Bart M Demaerschalk, MD, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mayo Clinic
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Teleneonatology (real-time neonatologist via audio-video link) | Standard care (no telemedicine support) |
|---|---|---|
| What it is | Participants receive advanced neonatal resuscitation at community hospitals with real-time, two-way audio-video connection to a neonatologist based at a regional neonatal intensive care unit (NICU). | Participants receive advanced neonatal resuscitation at community hospitals following the usual local practice, without telemedicine or remote neonatologist involvement. |
| Role in the trial | Serves as the experimental group to test whether telemedicine enhances advanced resuscitation outcomes for high-risk newborns in community hospitals. | Serves as the control group, receiving usual advanced resuscitation care without added telemedicine support. |
| Primary use | Designed to provide remote neonatologist support to community hospital clinicians during critical newborn resuscitation events. | Represents current practice where community hospital clinicians manage resuscitation independently, without telemedicine support. |
| How it is given or performed | A neonatologist communicates with the community hospital team via real-time video and audio link during the resuscitation, offering advice and oversight. | Resuscitation is managed by clinicians at the community hospital using local staff and protocols, without telemedicine or remote specialist involvement. |
| Evidence status | Effectiveness is not yet established. Prior research supports feasibility and acceptability of teleneonatology in simulated and clinical settings, but robust evidence for clinical effectiveness is still being developed. | Long-established standard of care in community hospitals, but outcomes may be limited by the absence of immediate specialist neonatologist input during advanced resuscitation. |
| Important limitations | Intervention effectiveness in real-world emergent neonatal situations remains unproven. Implementation may face technology, workflow, or acceptance barriers identified in pilot studies. | Limited access to instant neonatologist expertise may impact resuscitation quality in complex cases. No telemedicine means less specialist guidance in urgent situations. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - First hour of life
Participants receive telemedicine consultation by a neonatologist during advanced neonatal resuscitations in the delivery room at community hospitals, or receive usual care without telemedicine consultation.
1 delivery room event
Duration - 7 days
Participants are monitored for early mortality and morbidity outcomes within the first 7 days after birth.
Daily monitoring for up to 7 days
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jennifer L Fang, Rachel Umoren, Hilary Whyte...
https://pubmed.ncbi.nlm.nih.gov/34583392/Jennifer L Fang, Rachel A Umoren, Hilary Whyte...
https://pubmed.ncbi.nlm.nih.gov/37208433/Jennifer L Fang, Hilary Whyte, Rachel Umoren...
https://pubmed.ncbi.nlm.nih.gov/35167373/Mayo Clinic
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor